tau Proteins: Clinical Trials

7 trials of tau Proteins, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated, 1 active not recruiting, 1 completed, 1 enrolling by invitation. 2 Early Phase 1, 2 Not applicable, 1 Phase 2, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Early Phase 12Terminated 2
Not applicable2Recruiting 1, Unknown 1
Phase 21Completed 1
Phase 41Enrolling by invitation 1

Follow tau Proteins: new trials by email Literature Review of tau Proteins trials Research Report on tau Proteins

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Identification of Diagnosis Biomarkers in the Tears of Alzheimer's Disease Patients: The COG-EYE Pilot Study
Basal tear collection for the analysis of metabo-lipidomic profiles and concentrations of protein biomarkers (Tau, phosphorylated Tau, Aβ 1-40, and Aβ 1-42), Collection of a blood sample (5 mL) for blood biomarkers analysis - Alzheimer Disease
Not applicableRecruitingUniversity Hospital, Tours902025-07-092025-10-07
Biomarkers Associated With Postoperative Cognitive Dysfunction
Intraoperative electroencephalography recording, Neurofilament light chain measurement, Tau protein measurement - Delirium, Postoperative Cognitive Dysfunction
Active not recruitingUniversity of Oxford452023-01-052025-06-22
Metabolic and Molecular Responses Under the Effect of Taurine Supplementation With and Without Multicomponent Training
Taurine and Exercise (Tau+Ex), Placebo and Exercise (PL+Ex), Taurine (Tau) - Sarcopenic Obesity
Not applicableUnknownUniversity of Sao Paulo602022-07-012022-06-29
Tau Imaging of Chronic Traumatic Encephalopathy
[F18]-T807, [F18]-Florbetapir, MRI/MRS - Chronic Traumatic Encephalopathy
Phase 2CompletedBrigham and Women's Hospital302015-01-012018-05-17
A Phase 0, Open Label, Multi-center Exploratory and Safety Study of [F-18]T807
[F18] T807 - Alzheimers Disease, AD
Early Phase 1TerminatedAvid Radiopharmaceuticals112012-07-012013-07-19
A Phase 0, Open Label, Multi-Center, Exploratory and Safety Study of [F-18]T808
[F18] T808 - Alzheimers Disease
Early Phase 1TerminatedAvid Radiopharmaceuticals122012-07-012013-07-19
Imaging of Brain Amyloid Plaques in the Aging Population
Pittsburgh Compound B (C-11 PiB), F-18 FDG, Tau (18-F-AV-1451) - Alzheimer's Disease, Dementia With Lewy Bodies
Phase 4Enrolling by invitationMayo Clinic80002008-04-012026-06-23

Conditions studied

Alzheimer Disease (4)  ·  Frontotemporal Dementia (2)  ·  Charcot-Marie-Tooth disease, Type 1F (1)  ·  Chronic Traumatic Encephalopathy (1)  ·  Cognitive Dysfunction (1)  ·  Delirium (1)  ·  Dementia (1)  ·  Dementia, Vascular (1)  ·  Lacerations (1)  ·  Lewy Body Disease (1)  ·  Pick Disease of the Brain (1)  ·  Plaque, Amyloid (1)  ·  Postoperative Cognitive Complications (1)

Sponsors

Avid Radiopharmaceuticals (2)  ·  Brigham and Women's Hospital (1)  ·  Mayo Clinic (1)  ·  University Hospital, Tours (1)  ·  University of Oxford (1)  ·  University of Sao Paulo (1)

Countries

United States (4)  ·  France (1)  ·  United Kingdom (1)

Top investigators

Ellen C de Freitas, Ph.D. (1)  ·  Martha E. Shenton, Ph.D. (1)  ·  Martyn Ezra (1)  ·  Val Lowe, M.D. (1)

NIH funding

R01AG011378 (1), U01AG006786 (1)